Publications by authors named "Dinesh Chaple"

Article Synopsis
  • Cardiovascular diseases affect 608 million people globally, causing 32% of deaths, and often require combination therapy targeting the RAAS and Neprilysin systems.
  • A new multi-target in-silico modeling technique (mt-QSAR) was developed to assess the inhibitory effects on Neprilysin and Angiotensin-converting enzymes, achieving around 90% accuracy using various machine learning algorithms on 983 chemicals.
  • The study’s findings, including virtual screening and molecular dynamics simulations, aim to aid in identifying new multi-targeted treatments for cardiovascular conditions.
View Article and Find Full Text PDF

Cardiovascular diseases (CVD) such as heart failure, stroke, and hypertension affect 64.3 million people worldwide and are responsible for 30% of all deaths. Primary inhibition of the angiotensin-converting enzyme (ACE) is significant in the management of CVD.

View Article and Find Full Text PDF

Unlabelled: The severe acute respiratory syndrome COVID-19 declared a global pandemic by WHO has become the present wellbeing worry to the whole world. There is an emergent need to search for possible medications. We report in this study a molecular docking study of eighteen molecules with the main protease (M) responsible for the replication of SARS-CoV-2 virus.

View Article and Find Full Text PDF
Article Synopsis
  • COVID-19 has been declared a global pandemic, creating an urgent need for new medications to combat the virus.
  • Researchers are investigating the main protease of SARS-CoV-2 and exploring active chemical constituents from a specific plant to understand how they interact with this protein.
  • The study reveals that compounds like 3,5-Dicaffeoylquinic acid and Quercetin show strong potential against the virus, with 3,5-Dicaffeoylquinic acid demonstrating the best affinity, indicating its promise as a new treatment option.
View Article and Find Full Text PDF

Caffeic acid (CA), a hydroxycinnamic acid possessing a variety of pharmacological activities, has caused a growing interest for the treatment of hyperlipidemia and associated conditions. This work endeavored to develop a novel formulation of CA-Phospholipon® 90H complex (CA-PC) using a solvent evaporation method. Scanning electron microscopy (SEM), differential scanning calorimetry (DSC), Fourier transform infrared spectrophotometry (FTIR), and powder X-ray powder diffraction (PXRD) was carried to confirm the formation of CA-PC.

View Article and Find Full Text PDF

Earlier, we have reported the synthesis and anti-inflammatory evaluation of different 3-(4H-1,2,4-triazol-3-ylthio)-N-substituted propanamide. In this article, we are reporting the various tautomeric forms of the most active anti-inflammatory compound, 3-(4H-1,2,4-triazol-3-ylthio)-N-phenylpropanamide (6a) and their virtual screening by molecular docking using six principle tautomeric forms. Docking analysis suggested that compound 3-(4H-1,2,4-triazol-3-ylthio)-N-phenylpropanamide (6a) bound with COX-1 selectively and drug receptor complex was stabilized by tautomerism.

View Article and Find Full Text PDF